Impacts of Low-Dose Total Glycosides of Tripterygium Wilfordii Plus Methotrexate on Immunological Function and Inflammation Level in Patients with Rheumatoid Arthritis

Overview

Journal Comput Math Methods Med

Publisher Hindawi

Specialty Medical Informatics

Date 2022 Aug 12

PMID 35959351

Authors

Yong Han

Jingri Jin

Fushun Wu

Zhiwei Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: This research mainly clarifies the impacts of low-dose- (LD-) total glycosides of Tripterygium wilfordii (GTW) plus methotrexate (MTX) on immunological function and inflammation level in patients with rheumatoid arthritis (RA).

Methods: We enrolled 106 RA patients treated in Yanbian University Hospital between July 2019 and July 2021, including 56 cases (research group) intervened by LD-total GTW plus MTX and 50 cases (control group) treated with MTX, in addition to conventional treatment given to both groups. The improvement in immunological function (immunoglobulin (Ig) A, IgG, and IgM), inflammatory cytokines (ICs; C-reaction protein (CRP), tumor necrosis factor- (TNF-), and interleukin-6 (IL-6)), incidence of adverse reactions (ARs), joint function, and patient satisfaction were observed and compared.

Results: Statistical better improvements of immunological function, ICs, and joint function were observed in the research group compared with the control group. Besides, patient satisfaction was higher and the incidence of ARs was lower in the research group.

Conclusions: LD-total GTW plus MTX is highly effective and safe in enhancing the immunity, lowering the inflammation level, and improving the joint function of RA patients.

Citing Articles

Retracted: Impacts of Low-Dose Total Glycosides of Tripterygium wilfordii plus Methotrexate on Immunological Function and Inflammation Level in Patients with Rheumatoid Arthritis.

Methods In Medicine C Comput Math Methods Med. 2023; 2023:9842325.

PMID: 37416117 PMC: 10322452. DOI: 10.1155/2023/9842325.

References

Scherer H, Haupl T, Burmester G . The etiology of rheumatoid arthritis. J Autoimmun. 2020; 110:102400. DOI: 10.1016/j.jaut.2019.102400. View

Wang X, Li T, Xue Z, Lyu C, Li H, Fan Y . [Clinical symptoms effect of Tripterygium Glycosides Tablets alone or combined with methotrexate in treatment of rheumatoid arthritis: a Meta-analysis]. Zhongguo Zhong Yao Za Zhi. 2019; 44(16):3533-3541. DOI: 10.19540/j.cnki.cjcmm.20190605.501. View

Bilger A, Plowshay J, Ma S, Nawandar D, Barlow E, Romero-Masters J . Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication. Oncotarget. 2017; 8(27):44266-44280. PMC: 5546479. DOI: 10.18632/oncotarget.17863. View

Lin Y, Anzaghe M, Schulke S . Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020; 9(4). PMC: 7226834. DOI: 10.3390/cells9040880. View

Radu A, Bungau S . Management of Rheumatoid Arthritis: An Overview. Cells. 2021; 10(11). PMC: 8616326. DOI: 10.3390/cells10112857. View

Ridgley L, Anderson A, Pratt A . What are the dominant cytokines in early rheumatoid arthritis?. Curr Opin Rheumatol. 2017; 30(2):207-214. PMC: 5805125. DOI: 10.1097/BOR.0000000000000470. View

van Vollenhoven R, Keystone E, Strand V, Pacheco-Tena C, Vencovsky J, Behrens F . Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial. Ann Rheum Dis. 2018; 77(4):495-499. DOI: 10.1136/annrheumdis-2017-212478. View

Guo H, Peng J, Wang X, Zhang K, Zhong G, Chen W . Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials. BMC Nephrol. 2021; 22(1):304. PMC: 8425142. DOI: 10.1186/s12882-021-02487-8. View

Misra D, Gasparyan A, Zimba O . Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatol Int. 2020; 40(11):1741-1751. PMC: 7467139. DOI: 10.1007/s00296-020-04694-2. View

10.

Smolen J, Szumski A, Koenig A, Jones T, Marshall L . Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial. Arthritis Res Ther. 2018; 20(1):8. PMC: 5771183. DOI: 10.1186/s13075-017-1484-9. View

11.

Jin Y, Wang Y, Wang S, Zhao Q, Zhang D, Feng X . The Efficacy of Glycosides Combined with LMWH in Treatment of HSPN in Children. Evid Based Complement Alternat Med. 2021; 2021:7223613. PMC: 8553442. DOI: 10.1155/2021/7223613. View

12.

Lassere M, Rappo J, Portek I, Sturgess A, Edmonds J . How many life years are lost in patients with rheumatoid arthritis? Secular cause-specific and all-cause mortality in rheumatoid arthritis, and their predictors in a long-term Australian cohort study. Intern Med J. 2012; 43(1):66-72. DOI: 10.1111/j.1445-5994.2012.02727.x. View

13.

Qu C, Lu Y, Liu W . Severe Bone Marrow Suppression Accompanying Pulmonary Infection and Hemorrhage of the Digestive Tract Associated with Leflunomide and Low-dose Methotrexate Combination Therapy. J Pharmacol Pharmacother. 2017; 8(1):35-37. PMC: 5370328. DOI: 10.4103/jpp.JPP_93_16. View

14.

Lu J, Wu W, Zhang M, Wang P, Niu M, Yang X . Wells Syndrome Successfully Treated with Tripterygium Glycosides. Clin Cosmet Investig Dermatol. 2021; 14:1029-1031. PMC: 8402950. DOI: 10.2147/CCID.S328578. View

15.

Zhu G, Han X, Wang H, Yang Y, Gao Y, Wang H . [Effect of Tripterygium Glycosides Tablets in treating rheumatoid arthritis:a systematic review and Meta-analysis]. Zhongguo Zhong Yao Za Zhi. 2019; 44(15):3358-3364. DOI: 10.19540/j.cnki.cjcmm.20190305.004. View

16.

Wang X, Zu Y, Huang L, Yu J, Zhao H, Wen C . Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis. Life Sci. 2017; 171:45-50. DOI: 10.1016/j.lfs.2017.01.004. View

17.

Schultz M, Keeling S, Katz S, Maksymowych W, Eurich D, Hall J . Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey. Clin Rheumatol. 2017; 36(7):1471-1478. DOI: 10.1007/s10067-017-3687-5. View

18.

Outzen C, Maron D, Nissen J, Munk J, Grau L, Juhl D . The influence of a novel edge enhancement software on image quality of DR hand images of patients with rheumatoid arthritis. Radiography (Lond). 2021; 27(3):877-882. DOI: 10.1016/j.radi.2021.02.006. View

19.

Smolen J, Aletaha D, McInnes I . Rheumatoid arthritis. Lancet. 2016; 388(10055):2023-2038. DOI: 10.1016/S0140-6736(16)30173-8. View

20.

Esposito A, Chu S, Madan R, Doyle T, Dellaripa P . Thoracic Manifestations of Rheumatoid Arthritis. Clin Chest Med. 2019; 40(3):545-560. PMC: 6994971. DOI: 10.1016/j.ccm.2019.05.003. View